These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26081561)

  • 21. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Nishimura M; Hsu JC
    Am J Cardiol; 2018 Jan; 121(1):131-140. PubMed ID: 29132650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
    Expósito V; Seras M; Fernández-Fresnedo G
    Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study.
    Corrao S; Argano C; Nobili A; Marcucci M; Djade CD; Tettamanti M; Pasina L; Franchi C; Marengoni A; Salerno F; Violi F; Mannucci PM; Perticone F;
    Eur J Intern Med; 2015 May; 26(4):243-9. PubMed ID: 25749554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological Complications of Renal Disease.
    Baluarte JH
    Semin Pediatr Neurol; 2017 Feb; 24(1):25-32. PubMed ID: 28779862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
    Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
    Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials.
    Proietti M; Lane DA; Lip GYH
    EBioMedicine; 2016 Jun; 8():309-316. PubMed ID: 27428440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants.
    Reinecke H; Engelbertz C; Schäbitz WR
    Stroke; 2013 Oct; 44(10):2935-41. PubMed ID: 24008579
    [No Abstract]   [Full Text] [Related]  

  • 31. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.
    Ghadban R; Flaker G; Katta N; Alpert MA
    Hemodial Int; 2017 Oct; 21 Suppl 2():S47-S56. PubMed ID: 29064182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review.
    Harmon JP; Zimmerman DL; Zimmerman DL
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):624-8. PubMed ID: 24100216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
    Wong CX; Odutayo A; Emdin CA; Kinnear NJ; Sun MT
    Am J Cardiol; 2016 Jun; 117(12):1934-41. PubMed ID: 27237624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease and stroke.
    El Husseini N; Kaskar O; Goldstein LB
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):500-8. PubMed ID: 25443575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation in CKD and ESRD.
    Leung KC; MacRae JM
    J Nephrol; 2019 Oct; 32(5):719-731. PubMed ID: 30689127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Westenbrink BD; Alings M; Granger CB; Alexander JH; Lopes RD; Hylek EM; Thomas L; Wojdyla DM; Hanna M; Keltai M; Steg PG; De Caterina R; Wallentin L; van Gilst WH
    Am Heart J; 2017 Mar; 185():140-149. PubMed ID: 28267467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.